Education
About Us
Working with TipRanks
Follow Us
TuHURA Biosciences (HURA)
NASDAQ:HURA
Total Valuation
TuHURA Biosciences has a market cap or net worth of $126.12M. The enterprise value is $91.68M.
Market Cap$126.12M
Enterprise Value$91.68M
Share Statistics
TuHURA Biosciences has 50,046,925 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,046,925
Owned by Insiders16.48%
Owned by Institutions0.63%
Financial Efficiency
TuHURA Biosciences’s return on equity (ROE) is -1.49 and return on invested capital (ROIC) is -119.28%.
Return on Equity (ROE)-1.49
Return on Assets (ROA)-1.09
Return on Invested Capital (ROIC)-119.28%
Return on Capital Employed (ROCE)-1.21
Revenue Per Employee0.00
Profits Per Employee-1.14M
Employee Count19
Asset Turnover0.00
Inventory Turnover0.54
Valuation Ratios
The current PE Ratio of TuHURA Biosciences is ―. TuHURA Biosciences’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value0.05
Price to FCF―
Price to Operating Cash Flow-6.81
PEG Ratio―
Income Statement
In the last 12 months, TuHURA Biosciences had revenue of 0.00 and earned -21.68M in profits. Earnings per share was -116.18.
Revenue0.00
Gross Profit-116.71K
Operating Income-17.65M
Pretax Income-21.68M
Net Income-21.68M
EBITDA-17.43M
Earnings Per Share (EPS)-116.18
Cash Flow
In the last 12 months, operating cash flow was -15.48M and capital expenditures -69.64K, giving a free cash flow of -15.54M billion.
Operating Cash Flow-15.48M
Free Cash Flow-15.54M
Free Cash Flow per Share-0.31
Dividends & Yields
TuHURA Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.37
52-Week Price Change-61.22%
50-Day Moving Average2.67
200-Day Moving Average3.49
Relative Strength Index (RSI)38.38
Average Volume (3m)596.94K
Important Dates
TuHURA Biosciences upcoming earnings date is Sep 30, 2025, Before Open (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateSep 30, 2025
Ex-Dividend Date―
Financial Position
TuHURA Biosciences as a current ratio of 3.68, with Debt / Equity ratio of 2.87%
Current Ratio3.68
Quick Ratio3.64
Debt to Market Cap0.00
Net Debt to EBITDA0.71
Interest Coverage Ratio-4.26
Taxes
In the past 12 months, TuHURA Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
TuHURA Biosciences EV to EBITDA ratio is 0.67, with an EV/FCF ratio of 0.79.
EV to Sales0.00
EV to EBITDA0.67
EV to Free Cash Flow0.79
EV to Operating Cash Flow0.79
Balance Sheet
TuHURA Biosciences has $8.51M in cash and marketable securities with $558.97K in debt, giving a net cash position of -$7.95M billion.
Cash & Marketable Securities$8.51M
Total Debt$558.97K
Net Cash-$7.95M
Net Cash Per Share-$0.16
Tangible Book Value Per Share$78.20
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for TuHURA Biosciences is $12.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.00
Price Target Upside410.64% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast97.61%